Abstract
Higher Incidence of Class II Human Leukocyte Antigen (HLA)Allosensitization in Patients Supported with Pulsatile Ventricular Assist Devices (VAD) M. Askar, A. Zhang, L. Klingman, M. Mastroianni, A. Nowacki, P. Reville, J. Gatto, S. Bakdash, N. Smedira, R. Starling, G. Gonzalez-Stawinski. Allogen Laboratoires, Cleveland Clinic; Doisey College of Health Sciences, St. Louis University; Department of Quantitative Health Sciences, Cleveland Clinic; College of Arts and Sciences, The Ohio State University; Clinical Pathology, Cleveland Clinic; Cardiothoracic Surgery, Cleveland Clinic; Cardiovascular Medicine, Cleveland Clinic.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
